S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NYSE:DHR

Danaher - DHR Stock Forecast, Price & News

$247.97
-0.20 (-0.08%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$247.60
▼
$252.86
50-Day Range
$239.75
▼
$277.00
52-Week Range
$233.71
▼
$303.82
Volume
1.86 million shs
Average Volume
2.63 million shs
Market Capitalization
$180.67 billion
P/E Ratio
25.70
Dividend Yield
0.40%
Price Target
$310.29

Danaher MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.79 Rating Score
Upside/​Downside
24.7% Upside
$310.29 Price Target
Short Interest
Healthy
0.52% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.37
Upright™ Environmental Score
News Sentiment
0.57mentions of Danaher in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$2.22 M Sold Last Quarter
Proj. Earnings Growth
7.89%
From $10.14 to $10.94 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Multi-Sector Conglomerates Sector

3rd out of 14 stocks

Process Control Instruments Industry

4th out of 11 stocks

See Top Rated MarketRank™ Stocks Here

DHR stock logo

About Danaher (NYSE:DHR) Stock

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Stock News Headlines

March 27, 2023 | finance.yahoo.com
Danaher Schedules First Quarter 2023 Earnings Conference Call
March 23, 2023 | americanbankingnews.com
Danaher Co. (NYSE:DHR) Receives $310.29 Consensus Price Target from Analysts
March 27, 2023 | Behind the Markets (Ad)
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
March 22, 2023 | finance.yahoo.com
For new HQ, Danaher spinoff chose Waltham over Denver, Chicago, Va.
March 22, 2023 | finance.yahoo.com
Danaher's (NYSE:DHR) investors will be pleased with their strong 163% return over the last five years
March 18, 2023 | americanbankingnews.com
StockNews.com Initiates Coverage on Danaher (NYSE:DHR)
March 18, 2023 | finance.yahoo.com
Danaher Corporation (NYSE:DHR) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
March 15, 2023 | finance.yahoo.com
Jack Welch's GE Legacy ended last week: R.I.P.
March 27, 2023 | Weiss Ratings (Ad)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
March 7, 2023 | finance.yahoo.com
Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies
March 6, 2023 | finance.yahoo.com
If EPS Growth Is Important To You, Danaher (NYSE:DHR) Presents An Opportunity
February 27, 2023 | finance.yahoo.com
The Zacks Analyst Blog Highlights NVIDIA, Visa, Toyota Motor, Costco Wholesale and Danaher
February 26, 2023 | finance.yahoo.com
Insiders at Danaher Corporation (NYSE:DHR) sold US$6.2m worth of stock, possibly indicating weakness in the future
February 24, 2023 | finance.yahoo.com
Top Stock Reports for NVIDIA, Visa & Toyota Motor
February 8, 2023 | finance.yahoo.com
Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto
February 6, 2023 | finance.yahoo.com
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 6, 2023 | finance.yahoo.com
Life Storage, Newmont, Danaher stocks move on reports of M&A activity
February 6, 2023 | finance.yahoo.com
Catalent Stock Surges After Report of Takeover Interest
February 6, 2023 | finance.yahoo.com
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
February 6, 2023 | za.investing.com
Catalent surges over 20% on Danaher takeover interest, Wall Street mixed on deal
February 6, 2023 | msn.com
Danaher said to be interested in acquiring contract manufacturer Catalent
February 6, 2023 | barrons.com
Catalent Stock Surges on Report of Danaher Interest. M&A May Be Back.
February 6, 2023 | finance.yahoo.com
Catalent stock rockets 21% premarket on report of takeover interest from Danaher
February 6, 2023 | finance.yahoo.com
Danaher Takes Interest in Life Sciences Firm Catalent
January 30, 2023 | finance.yahoo.com
Danaher: A Future-Focused Spinoff Value Play
January 26, 2023 | finance.yahoo.com
Danaher Corporation (NYSE:DHR) Q4 2022 Earnings Call Transcript
January 25, 2023 | finance.yahoo.com
Danaher Full Year 2022 Earnings: Beats Expectations
See More Headlines
Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Company Calendar

Ex-Dividend for 1/27 Dividend
12/29/2022
Last Earnings
1/24/2023
Dividend Payable
1/27/2023
Today
3/27/2023
Ex-Dividend for 4/28 Dividend
3/30/2023
Next Earnings (Estimated)
4/20/2023
Dividend Payable
4/28/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Process control instruments
Sub-Industry
Industrial Conglomerates
Sector
Multi-Sector Conglomerates
Current Symbol
NYSE:DHR
CUSIP
23585110
CIK
313616
Web
www.danaher.com
Phone
(202) 828-0850
Fax
202-828-0860
Employees
81,000
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$310.29
High Stock Price Forecast
$340.00
Low Stock Price Forecast
$265.00
Forecasted Upside/Downside
+24.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$9.65
Trailing P/E Ratio
25.75
Forward P/E Ratio
24.51
P/E Growth
2.04
Net Income
$7.21 billion
Net Margins
22.91%
Pretax Margin
26.35%
Return on Equity
17.97%
Return on Assets
9.88%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
1.89
Quick Ratio
1.52

Sales & Book Value

Annual Sales
$31.47 billion
Price / Sales
5.75
Cash Flow
$14.28 per share
Price / Cash Flow
17.40
Book Value
$66.52 per share
Price / Book
3.74

Miscellaneous

Outstanding Shares
728,580,000
Free Float
646,976,000
Market Cap
$181.05 billion
Optionable
Optionable
Beta
0.80

Social Links


Key Executives

  • Rainer M. BlairRainer M. Blair
    President, Chief Executive Officer & Director
  • Matthew R. McGrewMatthew R. McGrew
    Chief Financial Officer & Executive Vice President
  • Jose-Carlos Gutiérrez-Ramos
    Chief Science Officer & Senior Vice President
  • Sadik Kassim
    Chief Technology Officer
  • Brian W. EllisBrian W. Ellis
    Senior Vice President & General Counsel

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













DHR Stock - Frequently Asked Questions

Should I buy or sell Danaher stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DHR shares.
View DHR analyst ratings or view top-rated stocks.

What is Danaher's stock price forecast for 2023?

14 analysts have issued 12-month target prices for Danaher's shares. Their DHR share price forecasts range from $265.00 to $340.00. On average, they predict the company's stock price to reach $310.29 in the next twelve months. This suggests a possible upside of 24.5% from the stock's current price.
View analysts price targets for DHR or view top-rated stocks among Wall Street analysts.

How have DHR shares performed in 2023?

Danaher's stock was trading at $265.42 at the beginning of the year. Since then, DHR shares have decreased by 6.1% and is now trading at $249.20.
View the best growth stocks for 2023 here.

Are investors shorting Danaher?

Danaher saw a decrease in short interest in March. As of March 15th, there was short interest totaling 3,450,000 shares, a decrease of 7.3% from the February 28th total of 3,720,000 shares. Based on an average daily trading volume, of 2,510,000 shares, the short-interest ratio is currently 1.4 days. Approximately 0.5% of the shares of the stock are sold short.
View Danaher's Short Interest.

When is Danaher's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 20th 2023.
View our DHR earnings forecast.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) posted its quarterly earnings data on Tuesday, January, 24th. The conglomerate reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.46 by $0.41. The conglomerate had revenue of $8.37 billion for the quarter, compared to the consensus estimate of $7.90 billion. Danaher had a net margin of 22.91% and a trailing twelve-month return on equity of 17.97%. Danaher's quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the company earned $2.69 earnings per share.
Read the conference call transcript.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Wednesday, February 22nd. Shareholders of record on Friday, March 31st will be paid a dividend of $0.27 per share on Friday, April 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date of this dividend is Thursday, March 30th. This is a boost from the stock's previous quarterly dividend of $0.25.
Read our dividend analysis for DHR.

What ETFs hold Danaher's stock?

ETFs with the largest weight of Danaher (NYSE:DHR) stock in their portfolio include Invesco Water Resources ETF (PHO), Alpha Intelligent - Large Cap Growth ETF (AILG), Invesco Global Water ETF (PIO), Franklin Genomic Advancements ETF (HELX), God Bless America ETF (YALL), Putnam BioRevolution ETF (SYNB), Pacer BioThreat Strategy ETF (VIRS) and Natixis Vaughan Nelson Select ETF (VNSE).

Is Danaher a good dividend stock?

Danaher (NYSE:DHR) pays an annual dividend of $1.00 per share and currently has a dividend yield of 0.40%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 10.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DHR will have a dividend payout ratio of 9.14% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DHR.

What is Rainer M. Blair's approval rating as Danaher's CEO?

27 employees have rated Danaher Chief Executive Officer Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among the company's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), Home Depot (HD), Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a number of retail and institutional investors. Top institutional investors include Moneta Group Investment Advisors LLC (3.20%), Geode Capital Management LLC (1.75%), Norges Bank (1.06%), Edgewood Management LLC (0.80%), Aristotle Capital Management LLC (0.69%) and Amundi (0.67%). Insiders that own company stock include Alan G Spoon, Angela S Lalor, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Elias A Zerhouni, Georgeann Couchara, Jennifer Honeycutt, Joakim Weidemanis, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Raymond C Stevens, Robert S Lutz, Teri List, Thomas Patrick Joyce Jr, Walter G Lohr and William King.
View institutional ownership trends.

How do I buy shares of Danaher?

Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $249.20.

How much money does Danaher make?

Danaher (NYSE:DHR) has a market capitalization of $181.56 billion and generates $31.47 billion in revenue each year. The conglomerate earns $7.21 billion in net income (profit) each year or $9.65 on an earnings per share basis.

How many employees does Danaher have?

The company employs 81,000 workers across the globe.

Does Danaher have any subsidiaries?
The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, Aldevron, Aldevron L.L.C., American Precision Industries, Applied Biosystems, Applitek NV, Aquatic Infomatics ULC, Aquatic Informatics, Armstrong Tools, BC Distribution BV, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biotechnology Suzhou Co. Ltd., Beckman Coulter Canada LP, Beckman Coulter Commercial Enterprise China Co. Ltd., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd, Beckman Coulter Laboratory Systems Suzhou Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Nederland B.V., Beckman Coulter Nippon GK, Beckman Coulter S.L.U., Beckman Coulter Saudi Arabia Co.Ltd., Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Finance ApS, Biacore International AB, Biosafe S.A., Blue Software LLC, Cepheid, Cepheid AB, Cepheid Canada ULC, Cepheid Europe SAS, Cepheid GmbH, Cepheid HBDC SAS, Cepheid India Private Limited, Cepheid UK Ltd., ChemTreat, ChemTreat Inc., Cispus Hong Kong Holding Limited, Cytiva, Cytiva BioProcess R&D AB, Cytiva Biotechnology Guangzhou Co. Ltd., Cytiva Biotechnology Hang Zhou Co. Ltd., Cytiva Europe GmbH, Cytiva Sweden AB, DCHL Holding BV, DH Denmark Holding ApS, DH Europe Finance II Sarl, DH Europe Finance Sarl, DH Holding Italia SRL, DH Holdings Germany LLC, DH II Luxembourg Sarl, DH Japan Finance Sarl, DH Switzerland Finance Sarl, DH Technologies Development Pte Ltd., DHCY Limited, DHKAB Company AB, DTIL Ireland Holdings Ltd., Danaher China Holdings Ltd., Danaher Finance Company AB, Danaher HK Holdings Ltd., Danaher Medical ApS, Danaher Shanghai Management Co. Ltd., Delta Consolidated Industries, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BV, Esko Graphics BV, Esko Graphics Inc., Esko Software BV, Fluke, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, Gilzoni Ltd., Global Life Sciences Solutions Austria GmbH & Co. KG, Global Life Sciences Solutions Germany GmbH, Global Life Sciences Solutions Korea Ltd., Global Life Sciences Solutions Manufacturing UK Ltd, Global Life Sciences Solutions Operations UK Ltd, Global Life Sciences Solutions Singapore Pte Ltd, Global Life Sciences Solutions USA LLC, Global Life Sciences Technologies Japan KK, Global Life Sciences Technologies Shanghai Co Ltd., Hach Company, Hach Lange GmbH, Hach Lange Sàrl, Hach Water Quality Analytical Instru. Shanghai Co. Ltd., HemoCue AB, HyClone Laboratories LLC, Hybritech Incorporated, Hyclone Life Sciences Solutions India Private Limited, ID Business Solutions Limited, IDBS Group, IRIS International, Imaging Sciences International, Immunotech Sro, Intabio LLC, Integrated DNA Technologies, Integrated DNA Technologies BVBA, Integrated DNA Technologies Inc., Integrated DNA Technologies Pte. Ltd., Intermountain Life Sciences LLC, Iris International Inc., KaVo, KaVo Kerr, Kaltenbach & Voigt, Keithley Instruments, Kipp & Zonen BV, Kollmorgen, Labcyte Inc., Laetus, Launchchange Holding Company, Leica Biosystems Imaging Inc., Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Biosystems Richmond Inc., Leica Instruments Singapore Pte Limited, Leica Microsystems, Leica Microsystems CMS GmbH, Leica Microsystems Cambridge Limited, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems Limited, Leica Microsystems UK Limited, Leica Mikrosysteme GmbH, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS, Life Sciences IP Holdings Corporation, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, MDS Analytical Technologies, Marconi Data Systems, Microtest, Molecular Devices, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Ltd., Nobel Biocare, OTT Hydromet Corp, Pall Aeropower Corporation, Pall Artelis BVBA, Pall Asia Holdings Inc., Pall Austar Lifesciences Limited, Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Canada ULC, Pall China Co. Ltd., Pall Corporation, Pall Europe Limited, Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group Inc., Pall France SAS, Pall GmbH, Pall India Pvt. Ltd., Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BV, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV Irish Branch, Pall Schweiz GmbH, Pall Technology UK Limited, PaloDEX, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., Precision NanoSystems, Precision Nanosystems ULC, Radiometer, Radiometer Medical ApS, Radiometer Turku Oy, Raytek, Reytek Corporation, Sea-Bird Electronics Inc., Sedaru Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Skyland Analytics Inc., Sutron, Swift Biosciences Inc., Sybron Dental Specialties, Tektronix, Thomson Industries, Trojan Technologies, Trojan Technologies Group ULC, VSS Monitoring, Vanrx Pharmasystems Inc., Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies Europe B.V., Videojet Technologies GmbH, Videojet Technologies Inc., Videojet Technologies S Pte.Ltd., Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Ray Optical Systems Inc., X-Rite, X-Rite Europe GmbH, X-Rite Incorporated, XOS, Yukon Hong Kong Holding Limited, and Zhuhai S.E.Z. Videojet Electronics Ltd..
Read More
How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The official website for the company is www.danaher.com. The conglomerate can be reached via phone at (202) 828-0850, via email at investor.relations@danaher.com, or via fax at 202-828-0860.

This page (NYSE:DHR) was last updated on 3/27/2023 by MarketBeat.com Staff